𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of neuroblastoma in mice with bromoacetylcholine and bromoacetate

✍ Scribed by Chung Y. Chiou


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
524 KB
Volume
67
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


Bromoacetylcholine (30 mg/kg intratumor one to three times per day) and bromoacetate (12 mg/kg intratumor two times per day) inhibited neuroblastoma in A/J mice efficiently and prolonged the lifespan of these animals at least 200%. Since the neuroblastoma-inoculated A/J mice are considered to be comparable to human neuroblastoma, the cytolytic action of bromoacetylcholine and bromoacetate on murine neuroblastoma warrants further studies on patients. The fact that these tumors were cured in adult mice is very important because older children and adults with neuroblastoma have the poorest prognosis.


πŸ“œ SIMILAR VOLUMES


Treatment of neuroblastoma with metaiodo
✍ Treuner, JΓΆrn ;Klingebiel, Thomas ;Bruchelt, Gernot ;Feine, Ullrich ;Niethammer, πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

Between April 1984 and December 1985 we treated ten children suffering from neuroblastoma in a total of 25 metaiodobenzylguanidine (MIBG) courses. Five had had a relapse of neuroblastoma stage III or IV, three had never achieved a remission in spite of intensive chemotherapy, and two were treated wi

Metaiodobenzylguanidine (mIBG) in treatm
✍ Klingebiel, Thomas ;Berthold, Frank ;Treuner, JΓΆrn ;Schwabe, Dirk ;Fischer, Manf πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 502 KB

From 1984 to 1989, 47 children with relapsed, refractory, and/or metastasized neuroblastoma were treated with 131I-metaiodobenzylguanidine (mIBG) in several different treatment combinations. At initial diagnosis, 36 children had Evans stage IV and 11 stage III disease. In 16 of the 47 children, tumo

Treatment of neuroblastoma with131I-MIBG
✍ Beierwaltes, William H. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 402 KB

Between 7/3/80 and 5/7/86 we gave 32 of our neuroblastoma patients 62 diagnostic doses of metaiodobenzylguanidine (MIBG) and 12 patients 20 treatment doses. Our conclusion from our diagnostic dose studies is that MIBG should be used for staging the extent of neuroblastoma before therapy is started,